🏥 Health & Medicine
Moderna made the mRNA technology behind one of the COVID vaccines — and rode it to roughly $19B of revenue at the peak. That boom is over: revenue has collapsed to ~$2B and the company now loses billions a year. The bet is that its mRNA *platform* — cancer vaccines, RSV, flu — produces the next hit before the COVID cash pile runs down.
Updated · Q1 2026 · March 2026
$2B / yr revenue · public since 2018
↻ The read keeps updating
You're reading the 6 opening chapters. After that, every time Moderna files a new report, the chapters get updated here.